Versant Capital Management, Inc Novo Cure LTD Transaction History
Versant Capital Management, Inc
- $710 Million
- Q3 2025
A detailed history of Versant Capital Management, Inc transactions in Novo Cure LTD stock. As of the latest transaction made, Versant Capital Management, Inc holds 3,622 shares of NVCR stock, worth $41,001. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,622
Previous 17,259
79.01%
Holding current value
$41,001
Previous $307,000
85.02%
% of portfolio
0.01%
Previous 0.05%
Shares
12 transactions
Others Institutions Holding NVCR
# of Institutions
290Shares Held
74.2MCall Options Held
1.26MPut Options Held
247K-
Black Rock Inc. New York, NY12.1MShares$137 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$118 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT9.64MShares$109 Million7.58% of portfolio
-
State Street Corp Boston, MA2.61MShares$29.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.47MShares$28 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.19B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...